These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31125000)

  • 1. Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men.
    De Sanctis V; Soliman AT; Daar S; Di Maio S
    Acta Biomed; 2019 May; 90(2):228-232. PubMed ID: 31125000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
    Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.
    Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J
    Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New modalities of transdermal testosterone replacement.
    Basaria S; Dobs AS
    Treat Endocrinol; 2003; 2(1):1-9. PubMed ID: 15871550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin reactions in a phase 3 study of a testosterone topical solution applied to the axilla in hypogonadal men.
    Muram D; Melby T; Alles Kingshill E
    Curr Med Res Opin; 2012 May; 28(5):761-6. PubMed ID: 22458919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.
    Gittelman M; Jaffe JS; Kaminetsky JC
    J Sex Med; 2019 Nov; 16(11):1741-1748. PubMed ID: 31551193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.
    Conaglen HM; Paul RG; Yarndley T; Kamp J; Elston MS; Conaglen JV
    J Sex Med; 2014 Feb; 11(2):574-82. PubMed ID: 24279472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Andrological testosterone replacement therapy].
    Paasch U; Glander HJ; Stolzenburg JU
    Urologe A; 2009 Jan; 48(1):79-86; quiz 87. PubMed ID: 19156339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.